Sugimoto T, Ikeda K, Kano J, Yamaguchi T, Fukase M, Chihara K
Department of Medicine, Kobe University School of Medicine, Japan.
J Cell Physiol. 1994 Feb;158(2):374-80. doi: 10.1002/jcp.1041580220.
The present study was designed to characterize the cross-talk of parathyroid hormone (PTH)-responsive dual signal transduction systems (cAMP-dependent protein kinase (PKA) and calcium/protein kinase C [PKC]) and its participation in PTH-induced homologous desensitization of intracellular calcium ([Ca2+]i) in osteoblastic UMR-106 cells. Although our recent study revealed that prolonged (more than 2 h) pretreatment with PKC-activating phorbol ester, phorbol 12-myristate 13-acetate (PMA) significantly decreased the PTH-stimulated cAMP production, pretreatment with PMA (10(-7) and 10(-6) M) but not 10(-6) M 4 alpha-phorbol 12,13-didecanoate (PDD), incapable of activating PKC for 30 min significantly augmented 10(-7) M hPTH-(1-34)-stimulated cAMP production. H-7 (50 microM), a PKC inhibitor, significantly antagonized this PMA-induced effect. Pretreatment with 10(-6) M PMA for 30 min did not affect PTH receptor binding but significantly augmented a cAMP responsiveness to 10(-5) M forskolin and 1 microgram/ml cholera toxin. Pertussis toxin (0.5 microgram/ml) did not affect the PMA-induced augmentation of the PTH-stimulated cAMP production. PTH caused a complete homologous desensitization of [Ca2+]i response within 30 min. Pretreatment with 10(-4) M dibutyryl cAMP for 30 min and 6 h significantly reduced and completely blocked the PTH-induced increase in [Ca2+]i, respectively. Pretreatment with 10(-4) M Sp-cAMPs, a direct PKA activator, for 30 min completely blocked the PTH-induced increase in [Ca2+]i. Rp-cAMPS (10(-4) M), an antagonist of PKA, slightly but significantly antagonized the PTH-induced homologous desensitization of [Ca2+]i response. The present study indicates that the time of exposure to PKC activation is a critical determinant in modulating the cAMP system, while PKA activation counterregulatorily acts on the [Ca2+]i system, and that PKA activation is linked to the PTH-induced homologous desensitization of [Ca2+]i response.
本研究旨在表征甲状旁腺激素(PTH)反应性双信号转导系统(cAMP依赖性蛋白激酶[PKA]和钙/蛋白激酶C[PKC])之间的相互作用,及其在成骨细胞UMR-106细胞中参与PTH诱导的细胞内钙([Ca2+]i)同源脱敏的过程。尽管我们最近的研究表明,用PKC激活剂佛波酯、佛波醇12-肉豆蔻酸酯13-乙酸酯(PMA)进行长时间(超过2小时)预处理会显著降低PTH刺激的cAMP生成,但用PMA(10^-7和10^-6 M)而非10^-6 M 4α-佛波醇12,13-十二烷酸酯(PDD)预处理30分钟,后者无法激活PKC,却能显著增强10^-7 M人PTH-(1-34)刺激的cAMP生成。PKC抑制剂H-7(50μM)能显著拮抗这种PMA诱导的效应。用10^-6 M PMA预处理30分钟不影响PTH受体结合,但能显著增强对10^-5 M福斯可林和1μg/ml霍乱毒素的cAMP反应性。百日咳毒素(0.5μg/ml)不影响PMA诱导的PTH刺激的cAMP生成增强。PTH在30分钟内导致[Ca2+]i反应完全同源脱敏。用10^-4 M二丁酰cAMP预处理30分钟和6小时,分别显著降低和完全阻断PTH诱导的[Ca2+]i升高。用10^-4 M Sp-cAMPs(一种直接的PKA激活剂)预处理30分钟完全阻断PTH诱导的[Ca2+]i升高。PKA拮抗剂Rp-cAMPS(10^-4 M)轻微但显著地拮抗PTH诱导的[Ca2+]i反应同源脱敏。本研究表明,暴露于PKC激活的时间是调节cAMP系统的关键决定因素,而PKA激活对[Ca2+]i系统起反向调节作用,并且PKA激活与PTH诱导的[Ca2+]i反应同源脱敏相关。